PNC FINANCIAL SERVICES GROUP, INC. - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 129 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,020
-25.1%
3,0000.0%0.00%
Q2 2023$5,370
-54.0%
3,0000.0%0.00%
Q1 2023$11,670
+14.4%
3,0000.0%0.00%
Q4 2022$10,200
-36.2%
3,0000.0%0.00%
Q3 2022$16,000
+14.3%
3,0000.0%0.00%
Q2 2022$14,000
-50.0%
3,000
-21.1%
0.00%
Q1 2022$28,000
+16.7%
3,8000.0%0.00%
Q4 2021$24,000
+9.1%
3,8000.0%0.00%
Q3 2021$22,000
-43.6%
3,8000.0%0.00%
Q2 2021$39,000
-78.2%
3,800
-77.7%
0.00%
Q1 2021$179,000
-31.9%
17,0100.0%0.00%
Q4 2020$263,000
+378.2%
17,010
+347.6%
0.00%
Q3 2020$55,000
-23.6%
3,8000.0%0.00%
Q2 2020$72,000
-1.4%
3,8000.0%0.00%
Q1 2020$73,0000.0%3,8000.0%0.00%
Q4 2019$73,000
+97.3%
3,8000.0%0.00%
Q3 2019$37,000
+60.9%
3,8000.0%0.00%
Q2 2019$23,000
+4.5%
3,8000.0%0.00%
Q1 2019$22,000
-38.9%
3,8000.0%0.00%
Q4 2018$36,000
+300.0%
3,800
+660.0%
0.00%
Q3 2018$9,000
+12.5%
5000.0%0.00%
Q2 2018$8,000
+14.3%
5000.0%0.00%
Q1 2018$7,0005000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders